🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will establish whether prolonged chronic dosing with secukinumab...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Start Date
2023-03-28
Trial ID
NCT05622708
Treatments Being Tested
The purpose of this study is to demonstrate the efficacy and safety of secu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-10-03
Trial ID
NCT02721966
Treatments Being Tested
The core and extension studies assessed the safety and efficacy of secukinu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-09
Trial ID
NCT01350804
This study will assess the safety and efficacy of secukinumab compared to p...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-06
Trial ID
NCT01365455
Treatments Being Tested
The study will assess the safety and efficacy of intravenous (10mg/kg) and ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-12
Trial ID
NCT01412944
Treatments Being Tested
The study compared the efficacy and assessed the safety of secukinumab give...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-10
Trial ID
NCT01359943
Treatments Being Tested
Given the role of IL-17 in the development of entheseal-driven pathology, a...
Status
Unknown
Location
Chinese Academy of Medical Sciences & Peking Union Medical College
Start Date
2021-07-15
Trial ID
NCT04967950
Treatments Being Tested
This study will assess the safety and efficacy of AIN457 as adjunctive ther...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2010-04
Trial ID
NCT01095250
The core and extension studies assessed the safety and efficacy of secukinu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-08-30
Trial ID
NCT01377012
Treatments Being Tested
This 3-year extension study aims at making available the treatment with sec...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-11-06
Trial ID
NCT01863732
Treatments Being Tested